Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
Multiple Myeloma Patients With a Long Remission After Autologous Hematopoietic Stem Cell Transplantation, Oren Pasvolsky, Zhongya Wang, Denái R Milton, et al.
STAT3 Protects Hematopoietic Stem Cells by Preventing Activation of a Deleterious Autocrine Type-I Interferon Response, Bhakti Patel, Yifan Zhou, Rachel L Babcock, et al.
Unsupervised Deep Representation Learning Enables Phenotype Discovery For Genetic association Studies of Brain Imaging, Khush Patel, Ziqian Xie, Hao Yuan, et al.
Training Robust T1-Weighted Magnetic Resonance Imaging Liver Segmentation Models Using Ensembles of Datasets With Different Contrast Protocols and Liver Disease Etiologies, Nihil Patel, Adrian Celaya, Mohamed Eltaher, et al.
Oncologic Outcomes in Patients with Localized, Primary Head and Neck Synovial Sarcoma, Riddhi R Patel, Vancheswaran Gopalakrishnan, Behrang Amini, et al.
Mechanical Venous Thrombectomy for Deep Venous Thrombosis in Cancer Patients: A Single-Center Retrospective Study, Riya M Patel, Koustav Pal, Syed Hadi Ahmed, et al.
Development and Assessment of a Point-of-Care Application (Genomic Medicine Guidance) for Heritable Thoracic Aortic Disease, Rohan Patil, Fatima Ashraf, Samer Abu Dayeh, et al.
Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts, Vinay K Pattalachinti, Ichiaki Ito, Saikat Chowdhury, et al.
Sequential Inhibition of PARP and BET as a Rational Therapeutic Strategy for Glioblastoma, Xin Peng, Xin Huang, Shaolu Zhang, et al.
The KRAS Mutational Spectrum and Its Clinical Implications in Pancreatic Cancer, Luigi Perelli, Giannicola Genovese, and Giulio F Draetta
The KRAS Mutational Spectrum and Its Clinical Implications in Pancreatic Cancer, Luigi Perelli, Giannicola Genovese, and Giulio F Draetta
A Structured Curriculum Supporting Biomedical Trainees’ Transition Into Independent Academic Positions and Early Career Success, Mabel Perez-Oquendo, Gabriele Romano, David P Farris, et al.
Role of the Antiparallel Double-Stranded Filament Form of FtsA in Activating The Escherichia coli divisome, Abbigale Perkins, Mwidy Sava Mounange-Badimi, and William Margolin
Determinants of Mosaic Chromosomal Alteration Fitness, Yash Pershad, Taralynn Mack, Hannah Poisner, et al.
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Regulates Phagocytosis in Glioblastoma, Mekenzie M Peshoff, Pravesh Gupta, Shivangi Oberai, et al.
Pre-COVID-19 Hospital Quality and Hospital Response to COVID-19: Examining Associations between Risk-Adjusted Mortality for Patients Hospitalised with COVID-19 and Pre-COVID-19 Hospital Quality, Doris Peter, Shu-Xia Li, Yongfei Wang, et al.
Analysis of Microbiome Data, Christine B Peterson, Satabdi Saha, and Kim-Anh Do
Pan-Cancer Proteogenomics Characterization of Tumor Immunity, Francesca Petralia, Weiping Ma, Tomer M Yaron, et al.
The Fatigue-Inducing Effects of Cancer and Its Therapy Are Characterized by Decreased Physical Activity in the Absence of Any Motivational Deficit, Thien T Phan, Kiersten S Scott, Brandon Chelette, et al.
Subsyndromes and Symptom Clusters: Multilevel Factor Analysis of Behavioral and Psychological Symptoms of Dementia With Intensive Longitudinal Data, Carolyn E Z Pickering, Vicki Winstead, Mustafa Yildiz, et al.
FAK Drives Resistance to Therapy in HPV-Negative Head and Neck Cancer in a p53-Dependent Manner, Phillip M Pifer, Liangpeng Yang, Manish Kumar, et al.
Phase II Study of Talazoparib in Advanced Cancers With BRCA1/2, DNA Repair, and PTEN Alterations, Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
Phase II Study of Talazoparib in Advanced Cancers With BRCA1/2, DNA Repair, and PTEN Alterations, Sarina A Piha-Paul, Chieh Tseng, Cheuk Hong Leung, et al.
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors, Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Ataxia-Telangiectasia Mutated Loss-of-Function Displays Variant and Tissue-Specific Differences across Tumor Types, Patrick G Pilié, Virginia Giuliani, Wei-Lien Wang, et al.